Mimedx MDXG
NASDAQ MDXG
$4.59 -0.05 (-1.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Mimedx (MDXG) Gains from Sales and Divestitures (2013 - 2024)

Updated

Mimedx's Gains from Sales and Divestitures was -$185,000 in Q1 2024.

Analysis

Mimedx (MDXG) Gains from Sales and Divestitures (2013 - 2024) Analysis & Trends

For FY2023, Gains from Sales and Divestitures at Mimedx came in at -$15,000.

  • In earlier years, Gains from Sales and Divestitures was $17,000 in FY2022, -$262,000 in FY2021, -$1,000 in FY2020 and -$318,000 in FY2019.
  • The Q1 2024 figure marks the lowest quarterly Gains from Sales and Divestitures since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Mimedx 668.88 Mn 65.06 Mn 44.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -185,000.00
Dec 31, 2023 -15,000.00
Sep 30, 2022 2,000.00
Mar 31, 2022 15,000.00
Dec 31, 2021 -26,000.00
Mar 31, 2021 -236,000.00
Dec 31, 2020 -1,000.00
Sep 30, 2020 1,000.00
Jun 30, 2020 -1,000.00
Sep 30, 2019 -5,000.00
Jun 30, 2019 -312,000.00
Mar 31, 2019 -1,000.00
Sep 30, 2017 4.27 Mn
Dec 31, 2013 -28,641.00
API Access

Mimedx Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=MDXG&period=max&api_key=YOUR_API_KEY